| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Quality of life | |||||
|
RCT |
26 men In review |
Median score improvement in the NIH-CPSI for quality of life
–5 with mepartricin –1 with placebo |
P = 0.0046 |
Effect size not calculated | mepartricin |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.